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A primary indicator of success in the fight against COVID-19 is avoiding stress on critical care 
infrastructure and services (CCIS). However, CCIS will likely remain stressed until sustained 
herd immunity is built, either in due course or by vaccination on mass scale. There are also 
secondary considerations for success: mitigating economic damage; curbing the spread of 
misinformation, improving morale, and preserving a sense of control; building global trust for 
diplomacy, trade and travel; and restoring reliability and normalcy to day-to-day life, among 
others.  We envision technology plays a pivotal role.  Here, we focus on the effective use of 
readily available technology to improve the primary and secondary success criteria for the fight 
against SARS-CoV-2. In a multifaceted technology approach, in this Part I, we start with 
effective technology use for remote patient monitoring (RPM) of COVID-19 with the following 
objectives:  
1. Deploying readily available technology for continuous real-time remote monitoring 
of patient vitals with the help of biosensors on a large scale. 
2. Effective and safe remote large-scale communitywide care (mass health monitoring 
with a cognitive AI platform) of low-severity cases as a buffer against surges in 
COVID-19 hospitalizations to reduce strain on critical care services and emergency 
hospitals.  
3. Improving the patient, their family, and their community’s sense of control and 
morale. 
4. Proposing a clear technology and medical definition of remote patient monitoring for 
COVID-19 to address an urgent technology need; address obfuscated, narrow, and 
erroneous information and provide examples; and urge publishers to be clear and 
complete in their disclosures.     
5. Leveraging the cloud-based distributed cognitive RPM platform for community 
leaders and decision makers to enable planning and resource management, pandemic 
research, damage prevention and containment, and receiving feedback on their 
strategies and executions. More details to follow on this in Part II.    
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Social distancing and coordinated community action appear to slow the exponential increase in 
new COVID-19 cases1, 2 for the first wave of the pandemic. However, COVID-19 poses pressing 
challenges not seen with recent pandemics3, 4. The mortality rate and contagiousness of COVID-
19 is likely to be higher than that seen in the H1N1 pandemic in 20091, 2. The current pandemic 
is also compared to the 1918 Pandemic Influenza, which occurred in three waves across the 
spring, fall, and winter of 19183, 5.  Moreover, the 1918 Pandemic Influenza spread over a year, 
while COVID-19 reached a global scope within weeks. As of May 15, 2020, earlier strain on 
critical care infrastructure and services (CCIS) appears reduced to some degree; on the other 
hand, the inherent weakness of an in-person-care (also referred to as brick-and-mortar) model is 
apparent. The current standard of care, financial incentive structure6, and infrastructure relies 
heavily on brick-and-mortar based health services.  In waiting rooms, patients and non-patients 
are vulnerable to potential exposure to COVID-19. Patients with other chronic illnesses and 
conditions susceptible to COVID-19 complications are especially at risk. COVID-19 has 
upended earlier best practices. The critical care system is especially strained, leaving many 
traditionally high-risk patients without care6. Moreover, the pandemic has pushed health services 
at all levels to strained conditions not seen before. In extreme cases, some communities have 
seen their health and social care system brought to their breaking point as localities run out of 
personal protective equipment (PPE), ICU beds, and ventilators, among others. For some 
communities, rationing health services may be unavoidable7.          
Even in the most optimistic scenario—if pandemic history is any guide—the worst may be yet to 
come; the crisis may continue for up to the next 18 months1, 3, 4, 8. It is time to utilize the success 
of first wave containment—the accumulated time, experience, and community spirit—to prepare 
for a likely second wave9.  Technology has the capability and readiness to make a social impact 
not only within local communities, but globally. Raztan et al. report communication and data 
voids due to uncertainty around the trajectory of COVID-19; this uncertainly is one of the causes 
of fear and misinformation9.    
COVID-19 is evolving, and presents new, perplexing symptoms that are the subject of ongoing 
investigations10, 11, 12.  Tang et al. found that blood coagulation abnormalities (increased D-dimer 
and fibrin degradation product) were markers for COVID-19 mortality11. Thachil et al. in their 
guidance for COVID-19 coagulopathy, report a 3-fold increase in D-dimer values (among other 
coagulopathy markers) indicates a significant need for hospital care even if there are no other 
concerns12. They recognize that their guidance will change with evolving knowledge. Such a 
rapidly changing disease, healthcare guidelines, and community response requires a modular and 
scalable system for remote patient monitoring (RPM).  Our cognitive RPM system is up to the 
task as it is component- and cloud-based, and may be readily deployed in the cloud on demand.     
We propose remote patient monitoring (RPM) on a mass-scale (communitywide care) as one way 
to prepare for possible subsequent waves of rapid increase in SARS-CoV-2 infections; we refer 
to these rapid increases in COVID-19 cases as surges. The primary objective of RPM is to 
counter the uncertainties associated with COVID-19 and its surges.  We propose gathering 
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community wide continuous real-time COVID-19 patient data for all patients.  This data may 
help with understanding the progression of COVID-19 in individuals, the spread of it 
community wide, containment effectiveness for the community, and the community’s pandemic 
role 9. We recognize that progression, spread, containment, and pandemic role are topics of 
investigation in their own right. Our approach is to use a cloud-based AI platform (cognitive 
RPM system) to generate data and intelligence that may further the respective investigations. 
Besides the data and intelligence derived from it, we offer a unified and common source of data 
that may be cross referenced across different research disciplines related to progression, spread, 
containment, and pandemic role. The referential integrity and traceability of the data across 
disciplines, we believe, is one effective tool in combating surges and uncertainty surrounding 
COVID-19. In Part I, we primarily focus on progression and spread.  We hope to learn from the 
community and peer feedback on Part I, which may help us cover containment and pandemic 
role in Part II. Our systems approach—in this Part I and the proposed Part II—to counter 
COVID-19 is an approach called for by Ratzan et al. 9 in being prepared and proactive in 
preventing, managing, and mitigating COVID-19 surges. The systems approach may not only 
subdue adversities against health, health workers, and health infrastructure, but also challenges 
(covered in Part II) faced by businesses, civic planning, economic forecasting, and broader 
societal responses to the pandemic.   
II. COVID-19 Symptoms and Severity 
Remote patient monitoring (RPM) is proposed to care for patients with various diseases13, 14, 15, 16, 
17. In this paper, we focus on COVID-19.We divide patients into two categories based on their 
symptoms10:  
 Low-severity: Symptoms include fever, fatigue, myalgia, cough, sore throat, runny nose, 
sneezing, nausea, vomiting, abdominal pain, and diarrhea (these are associated with acute 
respiratory tract infection and digestive distress) 10. We also include high-risk (due to key 
mortality markers including high blood pressure, diabetes, blood coagulation 
abnormalities, COPD, etc.) patients suspected to have or tested positive for COVID-19, 
but who show no symptoms.  
 High-severity: Symptoms include pneumonia with hypoxemia,      < 92%. Acute 
respiratory distress syndrome (ARDS), shock, encephalopathy, myocardial injury, heart 
failure, coagulation dysfunction, and kidney injury10. We also include a three or more 
fold increase in D-dimer values based on current reports and guidance11,12. 
A low-severity COVID-19 patient may be referred for home based real-time monitoring with the 
cognitive RPM system. The AI-based cognitive RPM system monitors the patient for their 
propensity to a potential turn to high-severity.  If high-severity COVID-19 is expected or 
detected, patients, doctors, paramedics, hospitals, resource managers, and other city officials may 
be notified. A patient may be transferred directly to a hospital bed.    
III. Real-time vs On Demand Monitoring 
Real-time monitoring offers several benefits over on-demand monitoring. Real-time is used to 
mean many things in literature depending on context. In an engineering sense, a real-time 
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observation of an event indicates an inconsequentially small time lag (e.g., to maximize 
resolution) between the event and its observation, while maintaining continuity of observation 
over the duration of the event. Traditionally, engineers have accepted a tradeoff between 
resolution and sampling continuity. On demand monitoring sacrifices both sampling continuity 
and resolution to allow human consumption of the raw data. If we take 12 days18 as the 
progression duration of COVID-19, a typical real-time observation of the patient symptoms (e.g., 
with biosensors) may involve taking observations every second for the 12-day duration.  A ten-
minute reading of sensors on each of the ten days whether at home, online, or in a clinical 
setting, is not a real-time observation.  Sporadic observation of symptoms over the 12-day period 
are considered on-demand observations. 
An on-demand observation of an event that is valid over a given set of time intervals 
(representing fractions of the event’s duration) is time dependent. On the other hand, a 
continuous real-time observation over the event’s entire duration is time independent. Real-time 
and on-demand are context-sensitive concepts that depend on data variability of the process as a 
function of time. For a chronic disease like Type II diabetes, 12 evenly spaced blood sugar 
measurements in a day over a period of a month (e.g., the time between doctor’s office visits) 
may be regarded as real-time, taking into account a patient’s daily activities and 
metabolic/activity cycles in aggregate.  On the other hand, COVID-19 is a fast progressing 
disease that is fraught with uncertainties; ideally, we may want to emulate data collection 
frequencies used in an ER environment and collect readings continuously for almost every 
second. The need for such continuous real-time readings is validated by reports of rapid onset of 
life-threatening conditions in previously symptom-free patients10, 19.  Therefore, real-time data 
collection for COVID-19 may involve recording each relevant vital on the order of a second for 
about two weeks or until the infection is cleared. We name a set of relevant vitals along with its 
concurrently collected date-and-time stamp a data-point. A data-point is collected about every 
second, and it represents a snapshot of the patient’s condition that may allow a doctor to arrive at 
a diagnostic with reasonable confidence.  We use these definitions of real-time and data-point in 
the COVID-19 monitoring and diagnostic context.      
Typically, physicians are accustomed to on-demand measurements; the average doctor may find 
it adequate to collect one sample of SpO2 every hour to monitor a COVID-19 patient.  Real-time 
data in its raw form may be overwhelming and counterproductive for the doctor. Therefore, 
systems that collect real-time data need to include modules for analysis, proactive intelligence 
generation, and visualization so that the doctor’s productivity and effectiveness are improved. 
Real-time measurement and the large amount of data generated in the process is a prerequisite 
for machine learning and AI approaches to COVID-19 monitoring.  Unlike a doctor, the AI of 
the RPM system proposed here can monitor COVID-19 patients continuously without fatigue, in 
large volumes, with short notice, and without consuming critical ER (CCIS) resources.  Such a 
system can be part of the preparation for anticipated COVID-19 surges.  In practical scenarios, 
(see Appendix B: COVID-19 Case Studies and Use Cases), real-time data gathering is subject to 
disruptions.  A patient monitored by a real-time device may—knowingly or unknowingly—
disconnect the device; the device may experience outages or misuse; or connectivity from the 
patient’s home to the RPM server may suffer. These contingences may be addressed 
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technologically; moreover, similar contingencies may affect patients currently in ERs and 
hospitals. New challenges for such a real-time RPM system exist, and we address and overcome 
them with the cognitive AI platform. 
1. Privacy: Patients and doctors alike should raise privacy concerns in any large scale 
monitoring system.  As part of our cognitive AI system, we continue to comply with 
existing privacy laws and IRB approval (an independent expert review to ensure ethical 
methods).  
2. Data deluge: Data collection for direct human consumption increases productivity only 
up to a certain level; after that, human productivity plummets due to excess data. We 
solve this challenge by generating cognitive intelligence from the data and provisioning 
the intelligence just in time, to the right individual (or collaborating system), in the right 
format, and to the extent desired by the individual. With cognitive RPM, a doctor 
responsible for oversight of a large number of COVID-19 patients would be notified only 
after certain high-severity alarm conditions are met. Then the doctor may ask for 
justification related to the alarm condition.  Subsequently, the doctor may choose to 
remotely contact the patient in an on-demand session, or the doctor may direct 
paramedics to transport the patient to an ER.      
3. False positives or other inundation of information: Not all AI systems are the same. 
Tactically collected sensor data is not enough; doctors want generated tactical AI 
consolidated with other known facts to deliver actionable intelligence—also referred to as 
cognitive intelligence. Performance considerations for the cognitive RPM system’s alarm 
condition (transition from low- to high-severity symptoms) are provided in the 
Communitywide Care Performance Measurements section. The system may be 
configured to collect feedback from doctors and generate an evaluation of its own 
intelligence generation.     
4. Security: The cognitive AI platform employs contemporary security (e.g., securing of 
data per HIPAA, PCI, or custom client needs). Security along with privacy and 
performance are a core part of the platform’s design; they may be verified and improved 
during major release cycles.  
 
IV. RPM for COVID-19 
We propose a generic use case for self-administered RPM using biosensors (see Biosensors for 
COVID-19 Remote Monitoring) based on published criteria for determining COVID-19 
progression (see Diagnostics, Disease Progression, and Health Predictors) in real-time on the 
cognitive AI platform (see Appendix A: Real-Time Monitoring, Intelligence Generation, and 
Notification Distribution). We insist on real-time monitoring over on-demand monitoring due to 
uncertainties regarding COVID-19 progression, unexpected turn of symptoms to high-severity 
(e.g., due to hypoxia), and the potential inability of patients to notice a sudden turn for the worse; 
for example, silent hypoxia as reported by Levitan19.  While high-severity patients need 
hospitalization and potentially ER monitoring, low-severity patients’ use of hospital resources 
may exert undue strain on CCIS3. Real-time differentiation and identification of high-severity 
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patients from a pool of COVID-19 cases in a community under surge is the differentiating 
benefit of our proposal and use of the cognitive AI platform.  In our proposal, we: 
1. Monitor all positively tested COVID-19 cases with low-severity indicators in a 
community. 
2. Predict and identify—in real-time—inflection points from low- to high-severity; 
generate notifications of the inflection points as alarm conditions; deliver the 
notifications and the relevant supporting evidence to health-practitioners, paramedics, 
and authorized individuals; and make the relevant data and its analytics available on 
demand. 
3. Support critical care infrastructure and services (CCIS) in its existing format (there 
may not be enough time to modify, test, and validate the already efficient functions of 
CCIS; e.g. ER procedures may already be optimal). For example, feedback from 
hospitals, ER professionals, and paramedics may be utilized to derive alarm 
conditions; deliver them as real-time notifications; and provision supporting data to 
justify the alarm conditions to the notification recipients. 
4. Collect, analyze, and distribute the data—within regulatory compliance guidelines 
(e.g., HIPAA, security, role-based access, IRB review and its guidelines, FDA and 
CDC recommendations and guidelines, etc.)—to pandemic research; resource 
management; planning, prevention, and containment efforts; and community 
awareness and education efforts; among others. More details on this will be covered 
in Part II.   
 
A. COVID-19 remote-healthcare: On-Demand vs. Real-Time 
Both on-demand and real-time tools may be used for remote-health provisioning. The scope of 
this paper is limited to remote monitoring of patients experiencing symptoms of low-severity 
COVID-19. A patient diagnosed with or suspected to have worsening hypoxia or other medical 
complications needs care in a clinical or hospital setting. For remote monitoring of low-severity 
COVID-19 patients, we describe two approaches to remote-healthcare and their cost benefits:  
Approach I is on-demand remote monitoring of patients by their doctor, and Approach II is real-
time monitoring of patients by an AI system.  
B. Approach I: On-demand monitoring 
On-demand monitoring is widely covered in the literature and this is the only option currently 
available for remote monitoring. Real-time monitoring is not addressed in otherwise 
comprehensive guidelines of on-demand telehealth provided by HHS20. Some on-demand 
monitoring solutions are referred or implied in their disclosures to be real-time, though in reality, 
they are at best episodic-care approaches. At a scheduled time—at the request of the patient or 
the doctor—a doctor on a video or audio conference with a patient may gather symptoms and 
results of patient self-administered tests. The patient may use a measurement device at the 
discretion of the doctor to gather health data.  Successful implementation, cost-benefit, and 
challenges of on-demand monitoring are subject to: 
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a) The patient’s ability to follow the doctor’s directions in gathering diagnostic data. 
Typically, a doctor’s ability may be limited in guiding a patient to collect, note, and 
convey a meaningful data sample during the on-demand session. Several studies have 
reported varying degrees of success rates13, 14, 15, 16, 17. Patient training, ease of use of 
devices, intuitiveness of interfaces, and in-home support for the patients may be 
influencing factors for success of on-demand monitoring. 
b) Rapid symptom progression. For example, in the case of COVID-19, on-demand 
monitoring may miss rapid progression to high-severity symptoms. The doctor may 
primarily rely on and be limited by the episodic data collection strategy of the on-
demand session for diagnosis; potential red flags may be delayed or even missed. The 
success of this approach is primarily dependent on cooperation, communication, and 
joint understanding between the patient and doctor. 
c) User familiarity with the system. On-demand monitoring is a natural extension of 
medicine as it is practiced today. A phone call or a video call that the patients and the 
doctors are already familiar with may not differ significantly from on-demand 
monitoring (for example, a doctor asking for a patient to take his temperature during a 
video call).  In real-time AI monitoring, the possible involvement of a potentially 
opaque system—for real-time data collection, data analysis, and decision making—
may be perceived by both the patients and the doctors as novel and may need some 
getting used to. 
d) Availability and scalability. On-demand solutions and their technology variations are 
readily available from several vendors. Though on-demand monitoring is promoted as 
a solution to remote monitoring of COVID-19, it is neither real-time continuous 
monitoring nor scalable. Patients may not be monitored continuously, and at any one 
time, only one patient can be monitored by one health care professional.  
 
On-demand—a dedicated limited-time communication link. An example of episodic monitoring 
as opposed to real-time monitoring.  
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C. Approach II: Real-time monitoring 
Continuous real-time patient monitoring by scalable, distributed, artificial intelligence based 
systems are, to the best of our knowledge, not in use or otherwise proposed in the literature. 
Based on reported COVID-19 spread2, 5, 8, 10 characteristics, we envision a need for mass-
monitoring of vitals that can be scaled up on short notice.  Most positive cases are expected to 
recover without leading to high-severity or life-threatening symptoms2, 5, 10; however, almost all 
low-severity cases would need continuous monitoring on a large scale (also referred to as 
communitywide care).  Though aggravation of symptoms may be sudden and unexpected, only a 
small fraction of COVID-19 cases is expected to exhibit life threatening conditions and need for 
ER care. As an illustration, we present typical communitywide care scenarios (see Appendix B: 
COVID-19 Case Studies and Use Cases) with the platform. We draw on our previous experience 
(see Appendix A: Real-Time Monitoring, Intelligence Generation, and Notification Distribution) 
in our proposal to design, implement, and test real-time data collection, intelligent screening, and 
notification in combating COVID-19.  
For the purposes of this paper, we consider home-based vitals monitoring scenarios (see 
Appendix B: COVID-19 Case Studies and Use Cases). This RPM scenario may be extended to 
emergency non-hospital quarantine locations in the event of a rapid surge in positive COVID-19 
cases.  We identify typical vitals, their thresholds, and alarm conditions that need monitoring, 
emphasizing rapid identification of patients with deteriorating conditions. Our objective is to 
identify patients that may need hospitalization and potentially ER care before their condition 
deteriorates to high severity. The success of communitywide care may be measured in terms of 
false positives and false negatives (see Communitywide Care Performance Measurements).  
Successful implementation of real-time monitoring, especially as compared to on-demand 
monitoring, depends on: 
a) Ability to emulate ER-like (continuous real-time) monitoring in non-hospital settings. For 
our home-based monitoring scenario, we need to collect data frequently and 
continuously.   In this context, we differentiate the cognitive RPM system from a generic 
continuous data collection system with smart phone app, graphs, and numerical displays. 
Our system can generate cognitive intelligence and deliver it just in time, to the right end 
users, in a format suited to the end user, with the extent of detail (e.g., metadata) 
specified by the end user. The deluge of information generated by the generic app is often 
detrimental to the cognitive productivity of the end user (e.g., doctor responsible for 
overseeing RPM for several patients). As an example, for a multi-tasking doctor, the 
cognitive RPM system shields the doctor from the data deluge, generates actionable 
intelligence, and delivers it to enhance the doctor’s cognitive productivity, induce 
intelligent insights, and reduce multi-tasking fatigue.   
b) Real-time analysis of and intelligence generation from the collected data to project the 
need for patient hospitalization to prevent life threatening conditions.  Our initial 
approach is for the cognitive RPM system to identify alarm conditions and generate and 
deliver real-time notification of the alarm conditions (e.g., to PCP, ER physicians, or 
paramedics) and, if needed, patient vitals history and PCP (primary care physician) notes. 
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We expect the availability of a patient’s vitals history and PCP notes at the time of ER 
admittance will reduce wait, processing and diagnosis time. 
c) Shifting COVID-19 patient screening burden from ERs and hospital waiting rooms to 
patient homes (or other designated quarantine locations). The patient’s PCP may monitor 
non-emergency progression of the disease or evaluate the need for hospitalization. This 
may also allow PCPs to see their non-COVID-19 patients in their regular practice.     
d) Bringing greater predictability to the progression of COVID-19 cases in a community by 
allowing the community and its administrators to monitor the progression of COVID-19 
in real-time, generate high-confidence projections, manage resources effectively, and take 
proactive steps to prevent expected future adversities. Details of this functionality will be 
provided in Part II.  
 
Continuous real-time patient monitoring by a scalable, distributed, AI-based system. Multiple 
patients can be accommodated simultaneously. The doctor is proactively alerted to patients who 
may require attention. 
V. Diagnostics, Disease Progression, and Health Predictors 
Rapid progression of COVID-19 and the resulting unprecedented pandemic motivated us to 
compile symptoms, severity and morbidity indicators, and related health features of the disease.  
The information in this paper is not health advice, a diagnostic indicator, or patient guidance.   
A patient’s COVID-19 health predictors may be divided into two categories: the patient’s vitals 
and the patient’s medical history. Vitals are measured in real-time to track progression and 
pinpoint potential deterioration to high-severity symptoms.  Real-time measurements of vitals is 
at the core of the cognitive RPM system. We propose a list of vitals that may need monitoring 
for effective real-time RPM. 
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A. Patient Vitals   
1. Respiratory Rate: This is the number of breaths per minute.  A normal range for adults is 
12 to 20 breaths per minute, with a lower number for individuals with better 
cardiovascular fitness. During COVID-19 progression, an increased respiratory rate over 
a short period of time may indicate a transition from low-severity to high-severity; this 
may be accompanied by shortness of breath. Breathlessness typically develops between 
day 521 and 822 of symptoms.  A review of risk factors for progression of COVID-19 
found that shortness of breath (dyspnea) is more significantly associated with mortality 
than presence of a fever23; dyspnea was reported in between 40 and 87% of patients23. 
Note that our objective is to generate an alarm condition in the cognitive RPM system 
well before the patient develops breathlessness or silent respiratory distress (such as the 
occurrence of silent hypoxia19) 
2. Blood Oxygen Saturation (SpO2): This measures the percentage of oxygen saturation in 
the blood.  Normal range is 95 to 100, and an alarm condition may be met for levels 
persistently below 92. This is likely the most important vital for COVID-19 patients.  
3. Heart Rate: Elevated heart rate (above 100 beats per minute) is believed to be one of the 
signs of worsening condition.  However, no published research linking elevated heart rate 
to COVID-19 was found.  
4. Blood Pressure: Numerous studies have found that patients diagnosed with hypertension 
have an increased risk of severe COVID-19 presentation and mortality24  
5. Temperature: Shi et al. report lack of positive correlation between fever and severity of 
COVID-1923.  
A patient’s continuous self-assessment of clinical symptoms is an important tool for determining 
alarm condition.  This is a subjective measure of symptom severity that depends on patient 
characteristics, behavior, and daily routine, along with their evaluation by the patient’s physician.     
B. Patient History 
Patient history guides predictors of mortality, propensity for high-severity symptoms, and 
expectations of outcomes in general. The current understanding of severity and mortality 
predictors may change due to uncertainty and lack of evidence-based guidelines from peer 
reviewed data on COVID-19. Currently, long-term effects of severe COVID-19 presentation or 
resulting damage to lungs or other organs are not known.  We propose to account for 
comorbidities24 (e.g., diabetes, hypertension, COPD or other respiratory diseases, underlying 
vascular disease, etc.) and other adverse factors (e.g., smoking, tobacco use, age over 65, history 
of lung or other cancer, etc.) from patient history in formulating an RPM alarm condition in Part 
I. We plan to cover community impact, use of data (e.g., for research, planning, communication, 
education, etc.), and potential use of the cognitive RPM system for studying the COVID-19 
pandemic in Part II.      
VI. Biosensors for COVID-19 Remote Monitoring 
Various telehealth and on-demand remote monitoring proposals have been reported—for 
example, RPM for management of chronic diseases14 including COPD15, 16 and diabetes6, and 
RPM as a part of mobile healthcare in rural and remote regions13. Though a wide variety of 
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devices are reported, not all devices are suitable for real-time monitoring; reporting on usability, 
efficacy, and reliability is in its early stages13. On the other hand, consumer wearables to self-
monitor and track personal fitness and health habits have been successful over the last decade.  
In the US, one in six fitness and health enthusiasts have used at least one device to self-monitor 
with a smart phone or smart watch26. Unlike clinical devices, consumer devices may lack key 
requirements for real-time RPM, including complete disclosure of technical specifications and 
supporting medical and efficacy data.  
Unlike for consumer devices, the rapid response needed for COVID-19 remote monitoring needs 
to account for accuracy and reliability of the self-administered devices. Consider, for example, 
oximeters as essential devices for monitoring COVID-19.  We find that the marketplace lacks a 
clear demarcation between clinical and consumer grade oximeters. PCP and ER doctors need to 
rely on the real-time and historic data to make potentially critical patient health decisions. A 
myriad of cheap devices is available from global suppliers that are not subject to US regulatory 
supervision or approval. In 2016, Lipnick et al. 25 reported four of six considered oximeters have 
subpar accuracy and reliability.  For hypoxia scenarios, four of the six reported errors for blood 
oxygen saturation (SpO2) levels < 80% and three of the six had errors for SpO2 levels 
between 80 − 90%.  Even FDA approved devices for use in clinical settings may not meet the 
World Federation of Societies of Anaesthesiologists standards25.  
Self-administration of remote devices may pose further challenges and is subject to erroneous 
readings due to an oximeter on a patient’s finger being susceptible to: hypoperfusion of the 
finger and its hand that is unrelated to patient health (e.g., reduction in natural blood flow due to 
the hand being relatively cold or due to vasoconstriction); the patient’s movements; and 
calloused skin on the finger.  Erroneous readings might also result from inability to follow 
instructions (e.g., in application, reading, and maintenance of the oximeter); operation of the 
oximeter outside its design specification (e.g., subjecting the oximeter to excess temperature or 
excess pressure—for example, by sleeping on it); and unexpected patient activity (e.g., physical 
exertion of a patient who is prescribed bed rest). We include the errors and potential 
misadministration of devices as a key factor in measuring effectiveness and efficacy of the 
cognitive RPM system (see Communitywide Care Performance Measurements).      
The cognitive AI platform is designed to generate intelligence from multiple IoT devices.  It can 
consume data from scientific (e.g., clinical grade for COVID-19 monitoring), commercial 
wearable, and commodity AV (audio video) devices concurrently to derive actionable 
intelligence. Cognitive intelligence generated by the platform may compensate for heterogeneity 
of IoT devices, an erroneous device reading, and patient-induced anomalies in measurements.    
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Cognitive RPM architecture: the cloud-based cognitive AI system can process various data from 
multiple devices and derive intelligence for the use of the PCP and other COVID-19 pandemic 
response. 
VII. Communitywide Care Performance Measurements 
The cognitive RPM system and its servers may be evaluated with functional and non-functional 
performance measures. Functional performance measures achievement of application-specific 
functionality. Non-functional performance accounts for general efficiencies and compliance of 
the platform. Appendix A: Real-Time Monitoring, Intelligence Generation, and Notification 
Distribution describes the core cognitive AI platform and its key non-functional performance 
indicators including bandwidth, CPU vs GPU usage, and computability in general. 
Here, we focus on functional performance measures for remote monitoring of COVID-19 
patients in their homes. While cognitive RPM functionality may be greatly influenced by the 
community, its jurisdictions, and its doctors, we present functional performance measures for a 
generic use case (see Appendix B: COVID-19 Case Studies and Use Cases).  The functionality 
represents intelligent abilities (a human equivalent) of the cognitive RPM system to meet target 
expectations. Three target tasks for the system are: 
1. Detect patient non-compliance: This is regarded as a challenge to real-time monitoring 
that may be overcome by patient training and regular (remote) oversight by health 
professionals. Patient non-compliance includes: 
a. Intentional or unintentional removal of sensors. For example, the system needs to 
detect removal of the sensors by the patient for a shower, bathroom break, 
unintentional removal of sensors, etc.  
b. Performing activities (e.g., exercise) which may alter sensor data against the 
advice of the doctor.     
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2. Detect faults in monitoring devices: Monitoring devices may generate faulty data or stop 
entirely due to: 
a. Low battery or lack or power. 
b. Adverse environmental conditions, e.g., high temperature, humidity, water 
immersion, etc. 
c. Loss of optimal device calibration.    
3. Diagnostics for COVID-19 symptoms: With patient compliance and fault-free devices, 
cognitive AI can process the generated data-points to deliver intelligent diagnostics and 
an alarm (if warranted based on alarm conditions).  Accuracy and time-to-delivery are 
important performance measures. 
 
A. Performance Criteria for Project Execution and Delivery 
 
Surges (of COVID-19 cases) are expected to continue into the next year1,3, 4. Rapid deployment 
of COVID-19 remote monitoring depends on several civic, healthcare, organizational, and 
technical criteria; some of the important ones are listed below:  
1. Multidisciplinary Execution Synergy: Rapid deployment and efficient execution may 
depend heavily on team members and stakeholders from healthcare, first responders, 
public policy, jurisdictional governance, civic planning, and technology. Execution plans 
need to account for efficient communication, go-no-go and milestones, and resource 
allocation, among others. A fast and effective delivery hinges on proactive initiative and 
participation from all areas of the team.  
2. User Adoption: User acceptance is key. Regardless of a jurisdictional mandate, a broader 
and informed community adoption of the technology solution hinges on training and 
familiarity. Frequent user feedback may dictate the efficacy of a remote monitoring 
solution. Findings, successes, and lessons learned need to be published in reproducible 
detail.   
3. Findings Transparency: Findings and lessons learned need to be published with clear 
definitions of success criteria, the extent to which the success criteria were met, and 
lessons learned. Urgency for a COVID-19 solution based on a scientific approach should 
not compromise reporting quality and detail; a political declaration in a research 
publication17 is counterproductive.       
4. Thoroughness of Disclosure: Promoters of COVID-19 technologies need to be aware of 
the unusual and urgent nature of the need. Devices and monitoring technologies implied 
to be COVID-19 ready need to meet the minimum criteria for technology readiness; e.g., 
clinical accuracy of devices need to be clearly stated and readily available25. A device 
that does not reliably generate continuous data streams in real-time is not (and should not 
be promoted as) ready for real-time time COVID-19 monitoring.   
5. Execution Details: Rapid planning, resource procurement, and execution are challenges 
for COVID-19 monitoring in their own right. Project management experts may have this 
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capability; however, they need to go beyond high-level objectives and goals and work out 
the finer project details; they need to expect and effectively execute pivots where needed.  
6. Funding Criteria:  
a. Project Funding: Traditional project funding sources need to look beyond “safe 
bets” but well short of “moon shots”. The execution plan and its capability are 
keys. Capable teams need to be proactively reached out to, and approval cycles 
need to be shortened. 
b. Health services payments: Healthcare systems are intertwined with a variety of 
payment models. Though a simple fee for service model is typically envisioned 
for remote monitoring services, challenges to other payments models remain6, 27. 
For digital services—and advanced remote monitoring—needs exist for 
reimbursement models, regulatory alignment, and feedback or evaluation criteria 
for efficacy and evaluation, among others.    
7. Uniqueness of Community Need: Frontline communities and their leaders are already on 
their toes.  They need to participate early and guide the effort to maintain the rapid pace 
of delivery for their own communities. Every community is unique and needs unique 
adaptation of a common execution plan. 
 
VIII. Conclusions 
COVID-19, as a highly contagious disease with a prolonged incubation period and possibility of 
sudden turn to life threatening conditions, has challenged the traditional healthcare approach. 
Currently, patients self-assess symptom severity and go to a hospital or ER waiting room for 
help. Even with increased testing, patient self-monitoring, self-assessment, and initiative are 
determining factors for visiting a hospital or ER waiting room. The cognitive RPM system 
addresses some of the key shortfalls of the traditional approach, which include: 
1. In brick-and-mortar (traditional) COVID-19 care, the time between the onset of high-
severity symptoms and a patient’s reporting to an ER, waiting for service, diagnosis, 
and eventual admission to the ER may span hours or longer; this time may be critical 
to COVID-19 care and recovery.  Cognitive RPM is designed to identify the first 
signs of high-severity symptoms and generate supporting diagnostic data for hospitals 
or ERs so that patients may avoid the waiting room. 
2. Waiting rooms are overwhelmed with patients with COVID-19 symptoms, causing 
stress on the health system, spread of COVID-19, and delayed care for patients in 
critical condition, among others.  Cognitive RPM may significantly reduce head 
count and time-to-care in waiting rooms; our goal is to eliminate COVID-19 cases 
from waiting rooms to avoid waiting room related pandemic spread.  
3. COVID-19 patient anxiety is centered on inability to get PCP care, self-monitor the 
disease, and stay informed of the progression. Cognitive RPM allows PCP to get 
involved in the early or low-severity symptoms stage of COVID-19 without 
disrupting care to non-COVID-19 patients. The patients informed by cognitive AI 
notifications and their own PCP may be more likely to follow social distancing and 
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other community guidelines to counter the pandemic. We plan to cover the wide 
effects of cognitive RPM on community pandemic response, healthcare planning, and 
ER resource management in Part II. 
4. Rural and sparsely populated communities where hospitals may not be nearby to 
handle COVID-19 surges face particular hardship in traditional healthcare settings.  
Cognitive RPM may provide not only in-home monitoring, but also PCP care from 
doctors in urban areas or available doctors in geographically distant communities.  
The ability to anticipate and plan for COVID-19 ER cases may reduce healthcare, 
economic, and resource strain on rural communities. 
Challenges to rapid COVID-19 pandemic community response  include difficulty in rapidly 
forming multidisciplinary teams of doctors, community leaders, and locally available 
technologists; lack of readily available funding; transparency and completeness of disclosures on 
devices, projects, and community initiatives; inability to address unique needs of individual 
communities; lack of execution guidelines and historic precedent; and slow pace of user adoption 
for pandemic related policies, technology solutions, and altered way of life due to the pandemic.  
We tackle some of these challenges in designing cognitive RPM, bringing together a 
multidisciplinary team, community involvement, and disclosure of information. Some others—
deploying and testing to create execution guidelines and assessing user adoption—remain due to 
their dependence on funding availability.    
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doctors. Our hope is to quickly bring community leaders, technologists, academics, and business 
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Appendix A: Real-Time Monitoring, Intelligence Generation, and 
Notification Distribution 
 
Cognitive RPM is supported by a privacy and security centric cognitive AI platform. It derives 
intelligence from deluges of real-time data collected from many heterogeneous IoT devices. The 
intelligence is delivered in real-time to the intended recipients, in their suitable format, exactly 
when needed. The system is a reusable, plug & play, versatile foundation for existing and future 
AI systems (for example, see the public safety application below). We bring three different 
innovations together to construct the cognitive AI platform.  
• It is a distributed, redundant, scalable, and fault tolerant pluggable framework of 
servers, networks, and bi-directional real-time asynchronous communication. 
Backward compatibility considerably simplifies interfacing with standards-based 
third-party systems regardless of their age. Our standards-based (e.g., XML and 
JSON) framework will allow us to grow without significant redesign, keeping up with 
future technology changes. 
• A variety of AI (as well as filter, analytics, and probabilistic) components may be 
plugged into the framework to achieve a range of design objectives. We have had 
success with deep neural networks (DNNs) optimized for specific tasks. 
• A suite of UI allows easy consumption of the generated intelligence and other 
messages. UI designs for all device form factors (smart phones, tablets, and 
desktops), major operating systems, and system types are ready. Further UI work is 
intended to bring more uniformity and intuitiveness to the system. 
Users can interface with AI systems supported by the cognitive AI platform through its 
Command and Control Console (C&CC). The C&CC is a real time cloud-based interface for 
administrators or a dashboard for decision makers. It presents a unified view of relevant media 
and aggregated intelligence.  Users can collaborate remotely through the console from anywhere 
in the world in real time (a low latency high-bandwidth underlying infrastructure is assumed). 
Collaborators may form groups and teams on the fly to consume, exchange, and deliver their 
expertise, which may be shared or added to the primary intelligence stream. It is secured by 
encryption, authentication, and authorization.  
We created a public safety application as a pluggable component of the cognitive AI platform. 
Among its numerous features is the ability to detect and locate wielded firearms. It achieves this 
by real-time monitoring of multiple video feeds simultaneously. Upon detection of a wielded 
firearm, the system immediately sends authorized end users notifications or alarms containing 
information needed to respond to the event. Notable advantages over traditional video 
surveillance include 1) live video analysis (with critical event information automatically reaching 
recipients within seconds, if not less) over a reactive approach, and 2) scalable automated 
monitoring of multiple feeds simultaneously (whereas humans lose monitoring ability with each 
additional screen). 
Page 20 of 21 
 
In a test of the prototype, we utilized a high-bandwidth (10 Gbps locally and 1 Gbps between 
datacenters) and low-latency (1 to 10 ms) geographically distributed network between Texas and 
Illinois.  Ping time between the server and the C&CC console was about 150 ms and reflected 
instantaneous network performance. In a public demonstration, we used two simultaneous live 
video streams, with a video processing backend to generate person, age, gender, and gun 
detection signals.  In the demonstration, we were restricted to the use of available CPU servers 
(32-CPU, 96 G Mem Ubuntu 16.04 LTS), which as expected, were the rate limiting steps. Use of 
CPUs (as opposed to GPUs), required reducing the video quality to 720p from 2K.  Adjustments 
to framerate, consistency of network status, and uniformity of server load proved to be critical 
factors to maintaining the steady state of the process. We maintained the steady state for about a 
month with average end-to-end system processing (SP) time between a wielded gun appearing in 
front of the camera to a notification of it appearing in the geographically separated admin 
console of about 400 ms. The gun notification was delivered to the end-user on their own 
handheld devices within about 450 ms.  In the public demonstration, the application exceeded the 
design goal, which was to send gun notifications within seconds.   
We conducted tests using mid to low-end GPUs for AI processing, which reduced the SP time to 
under 30 ms; notifications were delivered in less than 100 ms.  We anticipate that use of high-
end GPUs may eliminate AI processing as the rate-limiting step in its entirety.  We also 
successfully tested concurrent processing using multiple AI back ends.   
 
AI-based gun detection for a public safety application supported by our cognitive AI platform. 
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Appendix B: COVID-19 RPM Case Studies and Use Cases 
 
We use the following example case studies as basis for cognitive RPM use cases.  The case 
studies are intended to provide sample scenarios of COVID-19 remote monitoring for the benefit 
of non-medical collaborators—for example, community leaders and technologists. The diversity 
of and details in the case studies indicate a need for cognitive AI over tactical AI.   
Case Example 1:  
A doctor sees a 60-year-old man with chronic obstructive pulmonary disease (COPD) with a 
long history of smoking, diabetes and hypertension. This individual has had COPD exacerbations 
requiring hospitalization in the past, and tested positive for COVID-19. After three days of in-
hospital observation, the patient’s clinical status was stable (respiratory rate of 12 with an 
oxygen saturation of 95 on room air). The patient wanted to go home on the condition he would 
continue to self-isolate. Hospital staff educated and sent the man home with cognitive RPM 
technology. Since the patient has multiple health conditions, the physician set a lower alarm 
threshold for the patient’s oxygen status; the physician set the trigger at below 95% SpO2 instead 
of below 92% as for his younger patients without other significant health conditions. 
 
Case Example 2: 
A 30-year-old patient seeing a psychiatrist for a recent diagnosis of anxiety and history of panic 
attacks tests COVID-19 positive. The patient agrees to use cognitive RPM. On the third day of 
monitoring, the patient’s vitals become unstable (heart rate rises to 130 beats per minute, blood 
pressure of 150/90, and respiratory rate of 35 breaths per minute) for 5 minutes before returning 
to normal. This triggers the alarm and the physician is notified. The physician reviews the 
transient episode (associated data-points, intelligence, and metadata), calls the patient, confirms 
the patient was having an anxiety attack, and reassures the patient. This helped the patient avoid 
an emergency department visit. 
 
Case Example 3:  
A 75-year-old woman with heart failure with increasing work of breathing tests COVID-19 
positive and is monitored from home. The cognitive RPM technology alerted the doctor, who 
notified the ER and advised the patient to get right to the emergency department when her 
oxygen status began to gradually deteriorate. This prevented her having to wait in the hospital 
waiting room, and from potentially infecting individuals around her. She received medical care 
in the intensive care unit and was given a ventilator. An effective triage policy, social distancing 
in the community, and the RPM technology allowed the hospital to keep a steady supply of 
ventilators available. 
 
